Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson.

Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson.

<h4>Background</h4>Pharmacodynamic biomarkers are becoming increasingly valuable for assessing drug activity and target modulation in clinical trials. However, identifying quality biomarkers is challenging due to the increasing volume and heterogeneity of relevant data describing the bio...

Full description

Bibliographic Details
Main Authors: Sonja Hatz, Scott Spangler, Andrew Bender, Matthew Studham, Philipp Haselmayer, Alix M B Lacoste, Van C Willis, Richard L Martin, Harsha Gurulingappa, Ulrich Betz
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0214619

Internet

https://doi.org/10.1371/journal.pone.0214619

Similar Items